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Cellular mechanisms for controlling membrane trafficking appear to involve small GTP-binding proteins
such as the Rab proteins. Rab function is regulated by GDP dissociation inhibitor (GDI), which releases Rab
proteins from membranes and inhibits GDP dissociation. Here we report the isolation of a full-length cDNA
encoding a novel GDI isoform of 445 amino acids (GDI-2) with a deduced molecular weight of 50,649 from
mouse skeletal muscle. Full-length and partial cDNA clones encoding a previously reported GDI protein
(GDI-1) were also isolated from cDNA libraries prepared from rat brain and mouse skeletal muscle,
respectively. The degree of deduced amino acid sequence identity between mouse GDI-2 and our mouse GDI-1
cDNA clone is 86%. Northern (RNA blot) analysis revealed that in human tissues, both GDI-1 and GDI-2
transcripts were abundant in brain, skeletal muscle, and pancreas but were weakly expressed in heart and
liver. GDI-1 mRNA was expressed in kidney, whereas GDI-2 was almost absent, while in lung the relative
amounts of these mRNA species were reversed. Specific antibodies against mouse GDI-1 and GDI-2 based on
unique peptide sequences in the proteins were raised. Differentiation of 3T3-L1 fibroblasts into highly
insulin-responsive adipocytes was accompanied by large increases in both mRNA and protein levels of GDI-1
and GDI-2. GDI-1 and GDI-2 expressed as glutathione S-transferase fusion proteins were both able to
solubilize the membrane-bound forms of Rab4 and Rab5 in a GDP/GTP-dependent manner. Taken together,
these data demonstrate that the protein products of at least two genes regulate the membrane dynamics of Rab
proteins in mice.
Over the past several years, significant evidence implicating
p21l"-like small GTP-binding proteins in the mechanisms
driving membrane-trafficking pathways has been obtained (for
reviews, see references 1, 23, and 36). In particular, the
subfamily of Rab proteins appears to participate in vesicle
targeting or fusion events. The cycling of these proteins
between the inactive (GDP bound) and active (GTP bound)
states is believed to catalyze docking to specific target mem-
branes. Thus, in the sec4 mutant yeast strain, the fusion of
secretory vesicles to the plasma membranes is perturbed (27);
antibodies against Rabl and its yeast homolog, YPT1, block
transport between the endoplasmic reticulum and Golgi com-
plex (24, 26, 31); anti-Rab5 antibodies block early endosome
fusion (13); and antisense oligonucleotides against Rab3B
inhibit Ca-2-dependent exocytosis (18).
Three types of factors that regulate the interactions of
guanine nucleotides with the various Rab proteins have been
described: GTPase activating proteins, found for p25r3A (4)
and YPT1 (3), accelerate their intrinsic GTPase activity and
presumably catalyze their deactivation in vivo; GDP dissocia-
tion stimulators increase release of GDP from p25t""3A (5) and
the yeast counterparts SEC4 and YPT1 (20), allowing their
reactivation by binding to GTP; and GDP dissociation inhibi-
tor (GDI) inhibits the release of GDP from Rab proteins and
plays a role in the recycling of the Rab proteins from target to
donor membrane vesicles (30, 37). These regulatory proteins,
together with others now being identified, such as rabphilin
* Corresponding author. Mailing address: Program in Molecular
Medicine, University of Massachusetts Medical Center, 373 Plantation
St., Worcester, MA 01605. Phone: (508) 856-2254. Fax: (508) 856-
4289.
(32), are thought to compose a complex cellular system for
coordinating membrane trafficking.
Two GDI proteins have been identified for members of the
Rab subfamily (30, 37). One interacts with almost all of the
Rab proteins tested (29, 34, 38), while the other interacts with
Rabll (also designated 24K [37]) but not Rab3A (also desig-
nated smig p25A [30]). The former GDI cDNA has been cloned
from bovine brain, and its mRNA has been detected in all
tissues studied (19). It is also present in secretory cells with
both regulated and constitutive secretion pathways (22), where
it is found predominantly in the cytosol complexed with small
GTP-binding proteins (25, 34). Initial attempts to identify a
yeast counterpart of GDI with the bovine cDNA as a probe
under low-stringency conditions have not yet been successful
(29). These findings indicate that GDI proteins are important
modulators of GDP/GTP exchange reactions involving Rab
proteins and are potential candidates for regulation by cellular
signaling mechanisms.
Insulin stimulation of glucose uptake in fat and skeletal
muscle involves the redistribution of a major glucose trans-
porter isoform, GLUT4, from trans-Golgi or endosomal tubu-
lovesicular organelles to the plasma membrane (for a review,
see reference 9). Recent studies indicate that insulin modu-
lates both the exocytosis and endocytosis pathways of GLUT4
protein trafficking in fat cells (8, 16, 40). Several considerations
suggest that Rab proteins may also be involved in the mem-
brane movements of GLUT4 transporter proteins. The expres-
sion of a novel Rab protein (Rab3D) appears to be associated
with differentiation of 3T3-L1 fibroblasts to insulin-responsive
cells (2). Furthermore, the redistribution of Rab4 protein from
fat cell low-density microsomes to the cytosol in response to
insulin has recently been observed (7).
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To investigate the presence of GDI proteins in insulin-
sensitive tissues, we screened a mouse skeletal muscle cDNA
library for cDNA species encoding GDI proteins. We have
isolated a full-length cDNA encoding a novel GDI isoform
(mGDI-2) as well as a cDNA encoding the nearly complete
amino acid sequence of the GDI previously cloned from
bovine brain (mGDI-1). The mRNA and protein levels of both
GDI species were found to increase markedly upon differen-
tiation of 3T3-L1 fibroblasts and L6 myoblasts to insulin-
sensitive adipocytes and myocytes, respectively. Moreover, the
recombinant GDI-1 and GDI-2 proteins were able to modulate
the membrane association of Rab4 and Rab5 proteins. These
findings raise the possibility that GDI proteins may be involved
in insulin-regulated membrane recycling of glucose transport-
ers.
MATERIALS AND METHODS
Cell culture. L6 rat myoblasts (a gift from J. Lawrence,
Washington University, St. Louis, Mo.) were grown to conflu-
ence (150-mm plate) in Dulbecco's modified Eagle's medium
(DMEM) containing 10% calf serum, 50 U of penicillin per ml,
and 50 jig of streptomycin sulfate per ml. The differentiation of
L6 myoblasts was initiated by replacing the calf serum from the
above medium with 5% fetal horse serum. The composition of
the medium was kept the same until the end of the differen-
tiation program, with medium changes every 2 to 3 days.
Mouse 3T3-L1 fibroblasts were differentiated into adipocytes
as described previously (14). Briefly, fibroblasts were grown to
confluence (150-mm plate) in DMEM containing 10% calf
serum, penicillin (50 U/ml), and streptomycin sulfate (50
pLg/ml). Differentiation was induced with DMEM supple-
mented with 10% fetal bovine serum, penicillin (50 U/ml),
streptomycin sulfate (50 p.g/ml), insulin (5 ,ug/ml), 0.25 FxM
dexamethasone, and 0.5 mM 3-isobutyl-1-methylxanthine. On
the second day, the medium was replaced with DMEM con-
taining all but the last two of the above components. Thereaf-
ter, the cells were maintained in DMEM containing 10% fetal
bovine serum and the antibiotics, with medium changes every
2 to 3 days. COS-7 cells were grown (100-mm plate) in DMEM
containing 10% fetal bovine serum and the above antibiotics.
rGDI cloning. The coding region of rat GDI (rGDI) was
cloned by PCR from single-stranded cDNA from rat brain.
PCR was performed with oligonucleotides with the sequences
CTGACCATGGACGAGGA(A,G)TA(C,T)A and CGCG
GATCCTACTGGTCAGCTTCCCC(G,A)AA(G,A,C)AC
(parentheses indicate redundant positions) as described before
(39). The PCR product was cloned into mammalian and
bacterial expression vectors by using the flanking restriction
sites engineered into the oligonucleotides used for the PCRs.
The cDNA insert was fully sequenced after subcloning into
M13 vectors by the dideoxy nucleotide chain termination
method (28) with fluorescently labeled primers and Taq DNA
polymerase; sequencing reaction mixes were analyzed on an
ABI 370A DNA sequencer.
Screening of the mouse skeletal muscle cDNA library. A
mouse skeletal muscle cDNA library constructed in the X gtlO
bacteriophage vector (Clontech Laboratories) was screened
with the full-length rat brain cDNA for GDI described above.
The procedure was essentially that of Strauss (35). A total of
800,000 PFU were plated on the C600 Hfl strain of Escherichia
coli as the host (Clontech). The plaques were transferred onto
nitrocellulose filters (Millipore), alkali denatured, and fixed for
2 h at 80°C in a vacuum oven. The cDNA probe was 32p
labeled by random priming (10). The filters were hybridized in
6x SSC (1 x SSC is 150 mM NaCl, 15 mM trisodium
citrate - 2H20 [pH 7.0])-5 x Denhardt's solution (1 x Den-
hardt's solution is 0.02% each bovine serum albumin, polyvi-
nylpyrrolidone, and Ficoll)-50% formamide-10 mM EDTA-
0.5% sodium dodecyl sulfate (SDS)-25 pLg of denatured
salmon sperm DNA per ml at 42°C for 16 h and then washed
five times for 10 min each with 1 x SSC-0.1% SDS at 50°C.
The selected cDNA clones were subcloned into the EcoRI site
of pBluescript SK+ vector (Stratagene). The larger inserts
were further restricted with BamHI, PstI, or Hindlll (Pro-
mega) and again subcloned into the respective polylinker sites
of pBluescript for sequencing.
cDNA sequences were determined at least three times on
two strands by the dideoxynucleotide method (28) with Seque-
nase version 2.0 (United States Biochemical Corp.) and SK,
KS, T3, and cDNA-specific primers. DNA and protein se-
quence comparisons were carried out with CLUSTAL V
software (15).
RNA isolation. Total RNA was extracted from L6 or 3T3-L1
cells on various days of the differentiation programs by the
guanidinium thiocyanate method (6) with TRI (RNA/DNA/
protein isolation) reagent (Molecular Research Center, Inc.).
Polyadenylated [poly(A)+] RNA was selected by oligo(dT)-
cellulose chromatography with commercial columns and the
manufacturer's protocol (Molecular Research Center, Inc.).
Poly(A)+ RNA was dissolved in water, quantified by measur-
ing the A260, and subjected to electrophoresis on agarose gels
followed by ethidium bromide staining for analysis of its
integrity.
Northern (RNA blot) analysis. RNA transcript levels were
measured by Northern blot analysis. Poly(A)+ RNA (3 ,ug) was
fractionated on a formaldehyde-i% agarose gel and then
blotted and fixed onto a GeneScreen Plus nylon membrane
(DuPont NEN Products). The Northern blot of poly(A)+
RNA from different human tissues was obtained from Clon-
tech. The blots were hybridized with the GDI-1 or GDI-2
cDNA probe (32p labeled to 10' cpm/,ug by random priming)
for 16 h at 42°C in 5 x SSPE (1 x SSPE is 150 mM NaCl, 10
mM NaH2PO4 1H20, 1 mM disodium EDTA [pH 7.4])-50%
formamide-10 x Denhardt's solution-2% SDS-100 p.g of de-
natured salmon sperm DNA per ml. Blots were washed at a
final stringency of 0.1 x SSC-0.1% SDS at 67°C for 30 min.
The amounts of poly(A)+ RNA on the blots were controlled by
hybridization with labeled 3-actin cDNA (kindly provided by
David Hartley, Program in Molecular Medicine, University of
Massachusetts Medical Center, Worcester). Transcript levels
were quantitated by scanning the autoradiograms with an
enhanced laser densitometer (Ultrascan XL; LKB). Two ex-
posures of each blot were quantified to ensure that the
exposures were within the linear range of the film.
Production of GST-GDI-1 and GST-GDI-2 fusion proteins.
The entire mGDI-2 protein was expressed as a glutathione
S-transferase (GST) fusion protein by using the pGEX-1
vector (Amrad). In order to delete the flanking nucleotide
sequence in the 5' noncoding region of mGDI-2, a DNA
fragment was synthesized by PCR with the cloned isoform as a
template and oligonucleotides that contained an appropriate
restriction site 370 bp from the natural ATG start codon (5'
primer, CCGGAATTCATGAATGAGGAG; 3' primer, CTG
CTTCAGTGGAAGGA). The amplified DNA fragment was
isolated, digested with EcoRI and NcoI, and, together with the
NcoI-EcoRI fragment of mGDI-2 cDNA, was cloned into the
EcoRI site of pGEX-1 in frame with the GST gene.
To generate the GST-GDI-1 fusion protein, a 10-mer
double-stranded oligonucleotide (CATGGGATCC) carrying
BamHI and tailed with NcoI restriction sites was inserted in
frame with the initial Met codon into an NcoI digest of
MOL. CELL. BIOL.
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pET8c-rGDI-1 cDNA. The BamHI cDNA fragment of the
new vector encoding full-length rGDI-1 cDNA (1.4 kbp) was
subcloned into the BamHI site of pGEX-1 in frame with the
GST gene.
E. coli XA-90 was used for transformations. The new
vectors, pGEX-mGDI-2 and pGEX-rGDI-1, were confirmed
by sequencing. Transformed cells were grown and treated with
0.5 mM isopropyl-1-thio-3-D-galactopyranoside for 4 h. The
cells were lysed in buffer containing 50 mM HEPES (N-2-
hydroxyethylpiperazine-N'-2-ethanesulfonic acid, pH 7.4), 150
mM NaCl, 5 mM EDTA, 1% Triton X-100, 1 mM phenyl-
methylsulfonyl fluoride (PMSF), 1 mg of bacitracin per ml,
5 jig of aprotinin per ml, and 5 ,ug of leupeptin per ml by
sonication for 2 min and centrifuged at 12,000 x g for 25 min.
The supernatant was applied to glutathione-agarose beads
(Sigma) that were extensively washed with 50 mM Tris-HCl
(pH 8.0) containing 0.05% Triton X-100. The GST-GDI-1 and
GST-GDI-2 fusion proteins were eluted with the same buffer
containing 5 mM glutathione, which was then removed by
repeating ultrafiltration in a Centricon 30 microconcentration
unit (Amicon).
Epitope tagging and transient-expression assay. The full-
length rGDI-1 cDNA (1.4 kbp) was tagged in the NH2
terminus with a nine-amino-acid epitope, YPYDVPDYA,
derived from influenza virus hemagglutinin (HA) (11). Oligo-
nucleotides encoding the sequence detailed above after the
initial Met tailed with convenient restriction sites on the ends
(5', XbaI; 3', NcoI) were used. The double-stranded oligonu-
cleotide was inserted into an Xbal-NcoI digest of pET8c-
rGDI-1 cDNA. The HA-GDI-1 cDNA fragment was sub-
cloned into mammalian expression vector pCMV5 (cloning
sites, XbaI and BamHI). The new vector, HA-rGDI-1 pCMV5,
was confirmed by sequencing. The full-length mGDI-2 was
tagged in the NH2 terminus with an 11-amino-acid epitope,
EQKLISEEDLN, derived from the human c-myc proto-onco-
gene product (21). Oligonucleotides encoding the sequence
detailed above after the initial Met tailed with convenient
restriction sites (PstI and EcoRI) were used. The double-
stranded oligonucleotide was ligated into a PstI-EcoRI digest
of pBluescript-mGDI-2 cDNA that lacked the 5' noncoding
region of cloned mGDI-2 (deleted by PCR as described
above). The vector pBluescript-c-myc-mGDI-2 was confirmed
by sequence analysis. The PstI-SalI c-myc-mGDI-2 cDNA
fragment was further subcloned into the PstI-SalI digest of
pCMV5.
COS-7 cells were seeded at 750,000 cells per 100-mm plate,
and transfection of HA epitope-tagged rGDI-1 and c-Myc
epitope-tagged mGDI-2 cDNAs was performed by the calcium
phosphate precipitation method as described before (12). Cell
lysates were analyzed by Western blotting (immunoblotting) 48
h later.
In vitro dissociation assay. COS-7 cells (serum starved for 5
h before the experiment) were washed twice before homoge-
nization at 4°C in 20 mM HEPES buffer (pH 7.4) containing 1
mM EDTA, 250 mM sucrose, 1 mM PMSF, 5 jig of leupeptin
per ml, and S jig of aprotinin per ml. Equal amounts (120 ,ug
of protein) of postnuclear membrane fraction (two sequential
centrifugations [10 min at 800 x g and 15 min at 200,000 x g]
in a Beckman TL-100 Ultracentrifuge) were incubated for 30
min at 30°C in the presence or absence of the GST-GDI-1 or
GST-GDI-2 fusion protein or GST alone (each at 1 jiM) in a
reaction buffer consisting of 50 mM HEPES-KOH (pH 7.6), 5
mM MgCl2, 1 mM dithiothreitol, 1 mM PMSF, 5 jig of
aprotinin per ml, S jig of leupeptin per ml, and 1 jig of
pepstatin per ml. Where indicated, the membranes were
preincubated for 45 min at 30°C with GTPyS or GDP (each at
1 mM). The reaction mixtures were pelleted for 10 min at
200,000 x g, and the membranes and the soluble fractions
were analyzed for Rab4 and RabS content by fractionation by
SDS-polyacrylamide gel electrophoresis (PAGE; 10.5% poly-
acrylamide gel) and Western blotting with affinity-purified
anti-Rab4 antibodies (generously provided by Ira Mellman)
and affinity-purified monoclonal anti-RabS antibodies (gener-
ously provided by Marino Zerial) under the conditions de-
scribed below.
Cell lysis, cell fractionation, and immunoblotting. Trans-
fected COS-7 cells were washed twice with ice-cold phosphate-
buffered saline (PBS) prior to lysis with 1 ml of lysis buffer (50
mM HEPES [pH 7.5], 150 mM NaCl, 1 mM PMSF, 0.1% SDS,
0.5% sodium deoxycholate, 1% Nonidet P-40). Lysates were
incubated for 5 min on ice and clarified by centrifugation for 15
min at 16,000 x g. Equal amounts of total protein, as
measured by the bicinchoninic acid protein assay reagent
(Pierce), were fractionated by SDS-PAGE, transferred to
nitrocellulose, and blotted with anti-c-Myc monoclonal anti-
body, anti-HA monoclonal antibody, anti-mGDI-1 peptide
antiserum, or anti-mGDI-2 peptide antiserum under condi-
tions described elsewhere (33). Antibodies were detected by
enhanced chemiluminescence (Amersham).
For studying the relative amounts of mGDI-1 and mGDI-2
proteins in 3T3-L1 mouse fibroblasts and differentiated adipo-
cytes, the cells were first homogenized at 4°C in 20 mM
HEPES buffer (pH 7.4) containing 1 mM EDTA, 250 mM
sucrose, 1 mM PMSF, 5 jig of leupeptin per ml, and 5 jig of
aprotinin per ml. Cytosol fractions were obtained as described
above and analyzed by immunoblotting.
Antibodies. Rabbit polyclonal anti-GDI-1 and anti-GDI-2
antibodies are directed against an mGDI-1 peptide (amino
acids 431 to 447) and an mGDI-2 peptide (amino acids 386 to
404), respectively. The peptides were coupled via an amino-
terminal tyrosine to keyhole limpet hemocyanin. Antisera were
used at a dilution of 1:14,000 for immunoblotting. Mouse
monoclonal antibody 12CA5 (BAbCO), reactive with the
influenza virus HA epitope YPYDVPDYA (11), was used to
detect epitope-tagged HA-rGDI-1. Mouse monoclonal anti-
body ATCC 1729, reactive with the epitope EQKLISEEDLN
(21) derived from the c-myc proto-oncogene product, was used
to detect epitope-tagged c-Myc-mGDI-2.
RESULTS AND DISCUSSION
Isolation and nucleotide sequence analysis of mGDI-1 and
mGDI-2 cDNAs. To isolate cDNA clones encoding GDI
proteins expressed in muscle, we screened a mouse skeletal
muscle cDNA library with a probe corresponding to the entire
coding region of rat brain GDI under conditions of moderate
stringency. Seven recombinant plaques were found to be
strongly positive. One clone (pG4) exhibited weak hybridiza-
tion to this probe, suggesting that it may have been derived
from a new GDI-related gene. All eight recombinant plaques
were purified, and their EcoRI inserts (ranging in size from 1.3
to 3.7 kbp) were subcloned into pBluescript vectors. The
resulting plasmids were sequenced either directly or after
further appropriate restrictions and subcloning into pBlue-
script. Figure 1 shows the nucleotide sequence of the pG4
clone, designated mGDI-2. This mGDI-2 cDNA is about 2.4
kbp long and contains an open reading frame encoding 445
amino acids flanked by approximately 500 nucleotides on the
5' as well as the 3' sides. The predicted ATG initiation codon
conforms well with the canonical sequence for the mammalian
translation initiation start site proposed by Kozak (17). More-
over, the presence of an in-frame terminator upstream of this
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mGDI-2 AGTTTTCAGTTCGAGATTTTCTTCGTTCATATGCATCTTCTTCATCCTCT
mGDI-2 TCTCTGTCTCTTTTCTTGTCTTTCTCTCTTTCCCGTTCCCGTTCTCTCTC
mGDI-2 CCGTCTGAGGTGACGGCCGGCTCCCCGATCCACAGCTGAGTGTAGTCTCT
mGDI-2 GCCTCCGCTTCCGTTTTCCCTCGTGCCCCTTCTGGCCTGAGTGCTCGCCC
mGDI-2 CGCCGTCCGCCTCCTCCTCGGGGCAGCCGTAGCCCCAGACCCCTAGAGCT
mGDI-2 CTGAGCCTTCTCTGGGTCTCCGTCCGCGCCCGCCCCGCC
1 MetAsnGluGlu
mGDI-2 ATGAATGAGGA 11
mGDI-1 -----------
5 TyrAspValIleValLeuGlyHisTrpLeuThrGl uCysIleLeuSer
mGDI-2 GTACGACGTGATCGTGCTGGGGCACTGGCTGACGGAATGTATCCTGTCAG 61
mGDI-1 --------------------------------------------------
21 GlyIleMetSerValAsnGlyLysLysValLeuHisMetAspArgAsnPro
mGDI-2 GTATAATGTCAGTGAATGGCAAGAAAGTTCTTCACATGGATAGAAACCCG 111
mGDI-1 --------------------------------------------------
38 TyrTyrGlyGlyGluSerAlaSerIleThrProLeuGluAspLeuTyrLys
mGDI-2 TATTATGGAGGAGAGAGTGCATCTATAACACCGCTGGAAGATTTATACAA 161
mGDI-1 --------------------------------------------------
55 ArgPheLysIleProGlyAlaProProAlaSerMetGlyArgGlyArg
mGDI-2 AAGATTTAAGATACCCGGAGCTCCACCAGCATCCATGGGCAGAGGAAGAG 211
mGDI-1 --------------------------------------------------
71 AspTrpAsnValAspLeuIleProLysPheLeuMetAlaAsnGlyGlnLeu
mGDI-2 ACTGGAATGTTGACTTAATCCCCAAGTTCCTTATGGCAAATGGTCAGCTG 261
mGDI-1 -----------------------------------------------
88 ValLysMetLeuLeuPheThrGluValThrArgTyrLeuAspPheLysVal
mGDI-2 GTTAAGATGCTGCTTTTTACGGAGGTTACTCGCTATCTGGATTTCAAAGT 311
mGDI-1 --------------------------------------------------
105 ThrGl uGlySerPheVal TyrLysGlyGlyLysIleTyrLysValPro
mGDI-2 GACTGAAGGGAGCTTTGTTTATAAGGGAGGAAAGATCTACAAGGTTCCTT 361
mGDI-1 --------------------------------------------------
121 SerThrGl uAlaGl uAlaLeuAlaSerSerLeuMetGlyLeuPheGl uLys
mGDI-2 CCACTGAAGCAGAAGCCCTGGCATCTAGCCTAATGGGGCTGTTTGAAAAA 411
mGDI-1 GAGGCCTTGCGTTCTAATCTGATGGGCATGTTTGAAAAA
. ** *** ** **** ** ***** ***********
138 ArgArgPheArgLysPheLeuVal TyrValAlaAsnPheAspGl uAsnAsp
mGDI-2 CGTCGATTCAGAAAATTCCTGGTATATGTCGCCAACTTTGATGAGAACGA 461
mGDI-1 CGACGCTTCCGAAAATTTTTGGTGTTTGTGGCAAACTTTGATGAGAATGA
** ** *** ******* **** * *** ** ************** **
155 ProArgThrPheGl uGlyIleAspProLysLysThrSerMetArgGl u
mGDI-2 TCCTCGAACTTTTGAGGGCATTGATCCTAAGAAGACATCAATGCGAGAGG 511
mGDI-1 CCCCAAAACCTTTGAGGGTGTTGATCCCCAGAACACCAGCATGCGTGATG
** *** ******** ******* **** ** ***** ** *
171 Val TyrLysLysPheAspLeuGlyGlnAspVa l IleAspPheThrGlyHi s
mGDI-2 TGTATAAGAAATTTGACTTGGGCCAAGATGTTATAGATTTTACTGGTCAT 561
mGDI-1 TCTACCGGAAGTTTGACCTGGGTCAAGATGTCATAGATTTCACTGGCCAT
* ** *** ****** **** ******** ******** ***** ***
188 AlaLeuAlaLeuTyrArgThrAspAspTyrLeuAspGlnProCysCysGl u
mGDI-2 GCCCTGGCACTTTACAGAACTGATGACTATTTAGATCAGCCATGTTGTGA 611
mGDI-1 GCCTTGGCGCTCTACCGCACTGATGAGTACCTGGATCAGCCCTGTCTTGA
*** **** ** *** * ******** ** * ******** *** ***
205 ThrIleAsnArgIleLysLeuTyrSerGl uSerLeuAlaArgTyrGly
mGDI-2 AACCATTAATAGGATTAAACTTTACAGCGAATCTTTGGCAAGATACGGCA 661
mGDI-1 GACTATTAACCGCATCAAGTTGTACAGCGAGTCCCTGGCCCGGTATGGCA
** ***** * ** ** * ******** ** **** * ** ****
22lLysSerProTyrLeuTyrProLeuTyrGlyLeuGlyGluLeuProGlnGly
mGDI-2 AAAGCCCATACCTTTATCCACTCTACGGCCTTGGAGAACTGCCACAGGGA 711
mGDI-1 AGAGCCCCTATTTATACCCACTGTATGGCCTGGGTGAGCTGCCCCAGGGC
* ***** ** * ** ***** ** ***** ** ** ***** *****
FIG. 1. Nucleotide sequences of the cDNA clones for mGDI-1 and mGDI-2 and deduced amino acid sequence of mGDI-2. Identical
nucleotides are denoted by stars. The termination codon of mGDI-2 is marked (***), and the in-frame TAG upstream of the initiating Met codon
is underlined. Dashes denote unknown nucleotides of mGDI-1.
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238 PheAlaArgLeuSerAlalleTyrGlyGlyThrTyrMetLeuAsnLysPro
mGDI-2 TTTGCACGGCTAAGTGCTATATATGGAGGTACCTACATGCTGAATAAACC 761
mGDI-1 TTTGCCAGATTGAGTGCCATCTATGGGGGAACATACATGCTGAACAAACC
***** * * ***** ** ***** ** ** *********** *****
255 IleGluGluIleIleMetGlnAsnGlyLysValIleGlyValLysSer
mGDI-2 AATTGAAGAAATCATTATGCAAAATGGAAAGGTGATTGGTGTAAAATCTG 811
mGDI-1 AGTGGATGACATCATCATGGAAAATGGCAAGGTGGTGGGTGTCAAATCTG
* * ** ** ***** *** ******* ****** * ***** *******
27 lGluGlyGluIleAlaArgCysLysGlnLeuIleCysAspProSerTyrVal
mGDI-2 AAGGAGAGATTGCTCGCTGTAAGCAGCTCATCTGCGATCCCAGCTATGTG 861
mGDI-1 AGGGAGAGGTGGCCCGCTGCAAGCAGCTGATCTGTGATCCCAGTTACATC
* ****** * ** ***** ******** ***** ******** ** *
288 LysAspArgVal GluLysValGlyGlnValIleArgValIleCysIleLeu
mGDI-2 AAAGATCGAGTAGAAAAAGTGGGCCAGGTGATCAGAGTCATCTGTATTCT 911
mGDI-1 CCAGACCGTGTGCAAAAGGCTGGCCAGGTTATTCGCATCATCTGTATCCT
*** ** ** **** * ******** ** * ********** **
305 SerHisProlleLysAsnThrAsnAspAlaAsnSerCysGlnIleIle
mGDI-2 CAGCCACCCCATCAAAAACACCAATGACGCCAACTCCTGCCAGATCATTA 961
mGDI-1 CAGCCACCCCATCAAGAATACCAATGATGCCAATTCCTGCCAAATTATCA
*************** ** ******** ***** ******** ** ** *
321 IleProGlnAsnGlnValAsnArgLysSerAspIleTyrValCysMet Ile
mGDI-2 TTCCACAGAACCAAGTCAACCGGAAGTCAGATATCTACGTCTGCATGATC 1011
mGDI-1 TCCCTCAGAACCAGGTCAACAGGAAGTCAGACATCTATGTGTGCATGATC
338 SerSerAlaHisAsnValAlaAlaGlnGlyLysTyrIleAlaIleAlaSer
mGDI-2 TCCTCTGCACACAATGTGGCCGCACAAGGCAAGTACATCGCCATTGCCAG 1061
mGDI-1 TCCTATGCGCACAACGTGGCCGCACAGGGCAAATACATCGCCATTGCCAG
**** *** ***** *********** ***** *****************
355 ThrThrValGluThrLysGluProGluLysGluIleArgProAlaLeu
mGDI-2 CACAACGGTGGAGACCAAGGAGCCCGAGAAGGAAATCAGACCAGCCCTGG 1111
mGDI-1 CACCACTGTAGAGACTGCAGAACCAGAAAAGGAAGTTGAGCCTGCATTGG
*** ** ** ***** ** ** ** ****** * ** ** ***
37lGluLeuLeuGluProIleGluGlnLysPheValSerIleSerAspLeuLeu
mGDI-2 AGCTTTTGGAACCAATTGAGCAGAAATTCGTTAGCATCAGTGACCTCCTT 1161
mGDI-1 AGCTGTTGGAACCCATTGACCAGAAGTTTGTGGCTATCAGTGATTTATAT
**** ******** ***** ***** ** ** ******** * *
388 ValProLysAspLeuGlyThrGluSerGlnIlePhelleSerArgThrTyr
mGDI-2 GTACCAAAAGACTTGGGAACAGAAAGCCAGATCTTTATATCCCGTACCTA 1211
mGDI-1 GAGCCCATTGATGATGGTTCAGAGAGTCAGGTGTTCTGTTCCTGCTCCTA
* ** * ** ** **** ** *** * ** *** * ****
405 AspAlaThrThrHisPheGl uThrThrCysAspAspIleLysAspIle
mGDI-2 TGATGCAACAACTCACTTTGAGACGACCTGTGATGACATTAAGGACATCT 1261
mGDI-1 TGATGCTACCACACACTTTGAGACAACCTGCAATGACATCAAAGATATCT
****** ** ** *********** ***** ******* ** ** ****
421 TyrLysArgMetMetGlySerGl uPheAspPheGl uGl uMetLysArgLys
mGDI-2 ATAAGAGGATGATGGGATCCGAGTTTGACTTTGAGGAAATGAAGCGCAAG 1311
mGDI-1 ACAAACGCATGGCTGGTTCTGCCTTTGATTTTGAGAACATGAAGCGCAAA
* ** * *** ** ** * ***** ****** * ***********
438 LysAsnAspIl eTyrGlyGl uGl u * * *
mGDI-2 AAAAATGACATCTATGGGGAAGAGTAACAGCAGTACATGTTATCATCTAA 1361
mGDI-1 CAGAATGATGTCTTTGGAGAAGCTGATCAGTGATTGCTGACTCCCCTCCT
* ***** *** *** **** * *** * ** *
mGDI-2 TTAGGACAAACTTAAAATTTGGCAAATGATGCATATTGTATGAAATCAGT 1411
mGDI-1 CCAGCCCCTGTTCCCCTCTCCCCAACTTGTATGTCCTTCTCTAGGGCAGG
mGDI-2 ATTGTAAGGCCTGCTTTTGTAATCAAA
mGDI-1 GGAGATGGTATGGCTAGGCATCCTTGT
 at UNIV O
F M
ASS M
ED SCH on August 15, 2008 
m
cb.asm
.org
D
ow
nloaded from
 
3464 SHISHEVA ET AL.
bGDI
rGDI-1
mGDI-l
nGDI-2
bGDI
rGDI-l
mGDI-1
mGDI-2
bGDI
rGDI-l
mGDI-1
mGDI-2
bGDI
rGDI-l
mGDI-1
mGDI-2
bGDI
rGDI-1
mGDI-1
mGDI-2
bGDI
rGDI-1
mGDI-1
mGDI-2
bGDI
rGDI-1
mGDI-1
mGDI-2
bGDI
rGDI-1
mGDI-
mGDI-2
bGDI
rGDI-1
mGDI-l
nGDI-2
MOL. CELL. BIOL.
50
MDEEYDVIVLGTGLTECILSGIMSVNGKKVLHMDRNPYYGGESSSITPLE
*---------H---------------------------------------
100
.:::IPA: S::::::::::::::::::::::::::::F :::
D : :KIPGA: :AS-- :-- :-- :-- :-:--:--:-:-:--
150
DFK WEGSFVYKGGKIYKVPSTETEALASN1MGMFEKRRFRKFLVFVANF
-----------------------------.........:R:::m:::e:::.
200
DENDPKTFEGVDPQNTSMRDVYRKFDLGQDVIDFTGHALALYRTDDYLDQ
250
PCLETINRIKLYSESLARYGKSPYLYPLYGLGELPQGFARLSAIYGGTYM
300
...
..:....
. . . . ...................... ^*.
350
ICILSHPIKNTNDANSCQIIIPQNQVNRKSDIYVCMISYAHNVAAQGKYI
400
AIASTTVETTDPEKEVEPALELLEPIDQKFVAISDLYEPIDDGSESQVFC
450
;SCSAXTETTlCNDIDIZRMAGSAMDFNR DVL GED
:RT:::::::D:: :: :: :::M: :E: :::E:: ::K: :IY: :E*
FIG. 2. Alignments of deduced amino acid sequences of bovine brain smg p25A GDI (bGDI) (19), rat brain GDI-1, and mouse skeletal muscle
GDI-1 and GDI-2. Identical residues are denoted by colons, and replacements are indicated by the corresponding residue (one-letter code). The
missing first 124 amino acids of mGDI-1 are marked by dashes.
ATG (TAG, nucleotides -60 to -58) supports the concept
that this codon represents the translation initiator of the
GDI-2 gene product. The nucleotide sequence of the coding
region of the mGDI-2 cDNA is 72% identical to the bovine
brain smg p25A GDI (19) (Fig. 1).
Among the other clones isolated in this study was a 1.3-kbp
clone found to contain an open reading frame encoding 969
nucleotides and ending in a TGA stop codon, followed by
approximately 300 nucleotides in the 3' noncoding region (Fig.
1). The nucleotide sequence of the coding region of this cDNA
clone, designated mGDI-1, is 90% identical to that for the
bovine brain smg p25A GDI. However, this cDNA for mGDI-1
lacked the first 372 nucleotides of the predicted ATG transla-
tion start site of the smg p25A GDI. Nevertheless, the high
degree of homology between mGDI-1 and the bovine GDI
indicates that we have cloned a bovine brain smg p25A GDI
homolog from the mouse muscle library.
The comparison of the nucleotide sequences of mGDI-1 and
mGDI-2 presented in Fig. 1 suggests that these cDNA isolates
are derived from different genes. Differences in the two
sequences are distributed randomly along the entire cDNA
coding regions. Furthermore, the 3' noncoding regions are
distinct sequences. These findings and the fact that the two
cDNA clones were obtained from the same mouse muscle
cDNA library indicate that they encode two GDI protein
isoforms.
Figure 2 compares the deduced amino acid sequences of the
two isolated mouse muscle GDI cDNAs with that of the bovine
smg p25A GDI and rGDI-1. The overall sequence identity
between mGDI-2 and mGDI-1, mGDI-2 and smg p25A GDI,
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GDI-1 GDI-2
2.4kbp
_1.3kbp
1 2 3 4
FIG. 3. Southern blot analysis of mGDI-l and mGDI-2 cDNA
inserts for estimation of cross-hybridization. Equal amounts (-O..1 ng)
of the cloned mGDI-l (1.3 kbp, lanes 1 and 3) and mGDI-2 (2.4 kbp,
lanes 2 and 4) cDNA inserts were electrophoresed on a 1% agarose
gel, transferred to nitrocellulose, and hybridized sequentially with the
same radiolabeled cDNA inserts under high-stringency conditions.
Lanes 1 and 2, radiolabeled mGDI-l as a probe; lanes 3 and 4,
radiolabeled mGDI-2 as a probe.
and mGDI-2 and rGDI-1 is 85.7, 86.7, and 86.1%, respectively.
When conservative substitutions are eliminated, the sequence
similarities are 93.5, 93.8, and 93.1%, respectively. The degree
of sequence identity between mGDI-1 and smg p25A GDI and
between mGDI-1 and rGDI-1 is 98.1% in both cases. Interest-
ingly, many of the nonconservative substitutions between
mGDI-1 and mGDI-2 are concentrated in the C-terminal
region of the proteins.
Northern blot analysis of various tissues and insulin-
responsive cells. Previous studies have shown that smg p25A
GDI message is predominantly expressed in rat brain, although
it was also found in all other tissues tested (19). To analyze
whether the newly discovered mGDI-2 is specific for muscle,
we attempted to perform Northern blot analysis of various
human tissues. Since both GDI forms were found to recognize
mRNA transcripts of similar size (2.4 kb), pilot experiments
were performed to determine the conditions that eliminate
cross-hybridization. Figure 3 shows that under hybridization
conditions of relatively high stringency, this could be achieved
by using the radiolabeled 1.3-kbp mGDI-1 and 2.4-kbp
mGDI-2 cDNA isolates as probes. These conditions were thus
used for the Northern blot analysis.
Northern blots of mRNA prepared from various human
tissues probed with radiolabeled mGDI-1 and mGDI-2 cDNAs
are depicted in Fig. 4. This analysis revealed that GDI-2
mRNA was highly abundant not only in skeletal muscle but
also in lung (highest level), brain, and placenta. To a lesser
extent, the GDI-2 transcript was also detected in the other
tissues investigated, including heart, kidney, pancreas, and
liver. Brain, skeletal muscle, placenta, and liver also expressed
GDI-1
- 2.4 kb
GDI-2
- 2.4 kb
a)_ Cz b _CC Q U X>
-U -v-
-0 C0
_
.~
FIG. 4. Northern blot analysis of GDI-I and GDI-2 mRNA levels
in various human tissues. Each lane contained 1 ,ug of poly(A)+ RNA.
The same blot was hybridized sequentially with the radiolabeled
mGDI-1 (1.3 kbp) cDNA cloned in these studies and with the
full-length mGDI-2 cDNA insert (2.4 kbp) under high-stringency
conditions. sk, skeletal.
L6 CELLS 3T3-L1 CELLS
GDIC-1
-2.4 kb- -
GDI-2 -2.4 kb- aj 0
Vactin | t f-|a-2.0kb-| 0""
Day of -2 0 10 14 -2 4 10 14
differentiation
FIG. 5. Northern blot analysis of GDI-1, GDI-2, and 13-actin
transcript levels during differentiation of L6 myoblasts and 3T3-L1
fibroblasts. Each lane was loaded with 3 jig of poly(A)+ RNA isolated
from L6 and 3T3-LI cells on the indicated day of the differentiation
program. The same blots were hybridized sequentially with the radio-
labeled mGDI-1 (1.3 kbp), mGDI-2 insert (2.4 kbp), and 1-actin
probes under high-stringency conditions. A representative experiment
from three independent differentiations of each cell line is shown.
GDI-1 mRNA at levels apparently similar to those of GDI-2.
In contrast, kidney expressed predominantly GDI-1 mRNA,
while in human lung tissue, GDI-2 was the predominant
transcript present (Fig. 4).
The level of GDI-1 and GDI-2 mRNA species present in
3T3-L1 mouse cells and L6 rat cells was also determined by
Northern blot analysis. The cultured cell lines differentiate
from relatively insulin-unresponsive fibroblasts to highly insu-
lin-sensitive adipocytes and myocytes, respectively. After dif-
ferentiation, these cells express the GLUT4 glucose trans-
porter protein and exhibit insulin-mediated GLUT4
redistribution to the cell surface membrane (9). Both GDI-1
and GDI-2 transcripts were observed upon Northern blot
analysis of mRNA derived from L6 and 3T3-L1 fibroblasts
(Fig. 5). After differentiation, the levels of both GDI-1 and
GDI-2 mRNA species increased relative to the level of f-actin
mRNA present (7-fold and 3-fold, respectively, in L6 myo-
cytes; 10-fold and 5-fold, respectively, in 3T3-L1 adipocytes)
(Fig. 5). These data suggest that significant amounts of both
GDI protein isoforms exist in these cell lines and that the
amounts of these proteins increase in the fully differentiated,
insulin-responsive state.
Detection of endogenous and epitope-tagged GDI-1 and
GDI-2 proteins. In order to detect GDI proteins, we developed
specific antibodies against unique peptide sequences in
mGDI-1 and mGDI-2. Anti-GDI-1 antibodies were directed
against residues 431 to 447 in the C terminus of mGDI-1 and
recognized a major endogenous protein in COS-7 cell lysates
that appeared on SDS-PAGE as an apparent 55-kDa protein
band (Fig. 6, lane 3). Transient expression of the HA epitope-
tagged rGDI-1 in some cells resulted in the appearance of a
57-kDa band in a similar analysis (Fig. 6, lane 1). The
anti-GDI-1 peptide antiserum did not cross-react with the
endogenous GDI-2 but did recognize the higher amounts of
protein obtained by transiently overexpressing a c-Myc-tagged
mGDI-2 construct (apparent 48-kDa band, Fig. 6, lane 2).
Anti-GDI-2 antibodies directed against a peptide sequence
that is divergent between the two isoforms (residues 386 to 404
in the C-terminal region) detected a protein with an apparent
molecular mass of 46 kDa that migrated slightly faster than the
overexpressed c-Myc-mGDI-2 (Fig. 6, lane 5). Neither the
endogenous nor the expressed epitope-tagged rGDI-1 isoform
was detected by anti-GDI-2 antibodies (Fig. 6, lanes 4 and 5).
It is interesting that although both forms of GDI have deduced
.90
VOL. 14, 1994
 at UNIV O
F M
ASS M
ED SCH on August 15, 2008 
m
cb.asm
.org
D
ow
nloaded from
 
3466 SHISHEVA ET AL.
anti-GDI-1 anti-GDI-2 anti-myc anti-HA
1 2 3 4 5 6 7 8 9 10 11 12
HA-GDIrl
myc-GDI:2 _ 5OkDa
HA-GtDI- + - - + - - + - - + - -
myc-GDI-2 + + +
FIG. 6. Detection of endogenous and overexpressed forms of
GDI-1 and GDI-2 proteins in COS-7 cell lysates with anti-GDI-1,
anti-GDI-2, anti-HA, and anti-c-Myc antibodies. COS-7 cells tran-
siently transfected or not with HA-rGDI-1 or c-Myc-mGDI-2 were
lysed in 50 mM HEPES buffer (pH 7.5) containing 150 mM NaCl, 1
mM PMSF, 0.1% SDS, 0.5% sodium deoxycholate, and 1% Nonidet
P-40 and fractionated by SDS-10.5% PAGE. The electrophoresed
proteins were transferred to nitrocellulose and immunoblotted with
anti-GDI-1 peptide antiserum (1:14,000), anti-GDI-2 peptide anti-
serum (1:14,000), anti-c-Myc monoclonal antibody (1:500; ATCC
1729), and anti-HA monoclonal antibody (1:1,000; 12CA5), as indi-
cated.
molecular weights of about 51,000, the apparent molecular
masses determined by SDS-PAGE are 55 and 46 kDa for
GDI-1 and GDI-2, respectively.
The specific anti-GDI-1 and anti-GDI-2 antisera described
above were used to test whether increased GDI protein levels
are associated with 3T3-L1 cell differentiation, as suggested by
the data shown in Fig. 5. Cytosolic fractions obtained from
cultured 3T3-L1 fibroblasts and differentiated 3T3-L1 adipo-
cytes were analyzed by SDS-PAGE and Western blotting with
the antisera. As depicted in Fig. 7, the concentrations of
immunoreactive mGDI-1 and mGDI-2 proteins were elevated
approximately nine- and threefold, respectively, in the cultured
adipocytes compared with their levels in fibroblasts. These data
indicate that the acquired insulin sensitivity of 3T3-L1 adipo-
cytes is associated with marked increases in GDI protein levels.
Further data will be required to determine whether these or
other GDI proteins play a direct role in the altered membrane
trafficking of glucose transporters in response to insulin in
these cells.
GST-GDI-2 modulates membrane association of Rab pro-
teins. Several studies have demonstrated that bovine brain
GDI releases membrane-associated Rab proteins (25, 34, 38).
anti-GOC-1 anti-G DI-2
kDa1 2 3 41 kO
-- 80
GDI-2 ._
32
Day of -2 9
differentiation
-2 9
FIG. 7. Western blot analysis of protein levels of mGDI-1 and
mGDI-2 during differentiation of 3T3-L1 cells. Each lane was loaded
with 20 jig of cytosolic protein, obtained by homogenization (20 mM
HEPES buffer [pH 7.4] containing 1 mM EDTA, 250mM sucrose, and
protease inhibitors) and centrifugation (200,000 x g for 15 min in a
Beckman TL-100 Ultracentrifuge) of 3T3-LI cells on the indicated day
of the differentiation schedule. The proteins were analyzed by SDS-
PAGE, transferred to nitrocellulose, and immunoblotted with anti-
GDI-1 or anti-GDI-2 peptide antisera as indicated.
Membrane Soluble fraction
1 2 3 4 5 6 7
Rab4 |b __ = - 25kDa
GST + + +
GST-GDI-2 + + + -
GST-GDI-1 - - - - -- 4-
GDP + + - - + - +
GTP S +
FIG. 8. GST-GDI-2 and GST-GDI-1 release membrane-bound
Rab4. Postnuclear membranes of COS-7 cells were incubated for 45
min at 30°C with or without GDP or GTP-yS (each at 1 mM) as
indicated. The incubation was prolonged for an additional 30 min at
30°C in the presence or absence of GST alone, GST-GDI-1, or
GST-GDI-2 (each at I ,u M). The reaction mixtures were then
centrifuged, and the membrane and soluble fractions were analyzed
for their Rab4 content by SDS-PAGE and immunoblotting with
affinity-purified polyclonal anti-Rab4 antibodies. The position of Rab4,
as determined from the membrane fraction, is denoted by an arrow.
The second band detected in the soluble fraction is nonspecific. A
representative experiment from three independent membrane prepa-
rations is shown.
The close similarity between the sequences of mGDI-1 and
mGDI-2 indicates that the novel isoform may fulfill similar
functions. To address this question, we first generated a
recombinant GST-GDI-2 fusion protein. The electrophoretic
mobility of this expressed fusion protein (molecular weight,
75,000; not shown) corresponded well to the apparent molec-
ular mass of GST plus mGDI-2 as determined by SDS-PAGE
(see Fig. 6).
The ability of GST-GDI-2 to remove Rab4 protein from
membranes was assessed. As shown in Fig. 8, immunoreactive
Rab4 is associated with isolated membranes of COS-7 cells
(lane 1) and is not detected in the soluble fractions after
incubating cell membranes with GST (lanes 2 and 3). In
contrast, after incubation of membranes with the recombinant
GST-GDI-2 protein (1 plM), Rab4 was readily detected in the
soluble fraction (Fig. 8, lane 6). GDP (1 mM) only slightly
augmented this membrane dissociation of Rab4, while GTP-yS
abrogated it (Fig. 8, lanes 4 and 5). Since Rab4 in membranes
is presumably already in the GDP-bound form, this result
indicates that, similar to bovine brain GDI, GDI-2 binds to the
GDP-bound form of the Rab protein in membranes and
releases it into the soluble fraction. Under the conditions used
in these experiments, the capacity of our GST-GDI-2 fusion
protein at 1 p.M to solubilize Rab4 amounted to -15 to 20%
of the total membrane-associated Rab4 (Fig. 6, lane 5 versus
lane 1).
We next assessed the relative specificities of GDI-2 and
GDI-1 for extracting two members of the Rab family, Rab4
and Rab5, from membranes. We first generated a recombinant
GST-GDI-1 fusion protein with an electrophoretic mobility
(apparent molecular weight, 80,000; not shown) corresponding
well to the apparent molecular mass of GST plus GDI-1, as
judged by SDS-PAGE (see Fig. 6). Similar to GST-GDI-2,
GST-GDI-1 was able to extract membrane-associated Rab4
into the soluble fraction (Fig. 8, lane 7). GST-GDI-1 at a
concentration of 1 F.M solubilized an amount of total mem-
brane-associated Rab4 similar to that solubilized by GST-
GDI-2 in three separate experiments.
The ability of both fusion proteins to dissociate membrane-
bound RabS was also compared. As shown in Fig. 9, both
recombinant GDI isoforms were able to solubilize immunore-
MOL. CELL. BIOL.
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FIG. 9. GST-GDI-1 and GST-GDI-2 release membrane-bound
RabS. Postnuclear membranes of COS-7 cells were incubated (45 min,
30°C) with or without GDP or GTPyS (each at 1 mM) as indicated.
The incubation was prolonged for an additional 30 min at 30°C in the
presence or absence of GST alone, GST-GDI-1, or GST-GDI-2 (each
at 1 puM). The reaction mixtures were pelleted, and the soluble
fractions were analyzed for their RabS content by SDS-PAGE and
immunoblotting with affinity-purified monoclonal anti-Rab5 antibod-
ies.
active Rab5 when incubated with COS-7 cell membranes
(lanes 2 and 5). This effect was inhibited by GTPyS (Fig. 9,
lanes 4 and 7) and only slightly enhanced by GDP, probably
because of the predominance of GDP-bound RabS already
present in the membranes. These data suggest that both
rGDI-1 and mGDI-2 can function as regulatory proteins for
Rab4 and Rab5. However, we cannot conclude from these
experiments that subtle differences in the regulation of Rab4
and Rab5 proteins by GDI-1 versus GDI-2 are not also
physiologically important.
An important extension of the above experiments will be to
test the possibility that one or more of the other Rab proteins
are uniquely regulated by only one of the two GDI isoforms
studied here. This important question will be challenging to
address because of the large number of unique Rab protein
candidates to be screened. There is precedence for such
specificity. The purified form of the GDI for Rabl I does not
interact with Rab3A (37). The significant variations in the
amino acid sequences of GDI-1 and GDI-2, especially in the
C-terminal region, could serve as the basis for Rab-binding
specificity. However, other properties could also differ between
the two proteins, such as cellular localization, regulated phos-
phorylation, or other posttranslational modifications.
In summary, we have identified and characterized a novel
isoform of mammalian GDI that releases membrane-bound
Rab4 and RabS proteins and is widely expressed in primary
tissues and in insulin-responsive cultured cells. Thus, at least
two gene products in murine tissues carry out the functions of
GDI proteins in regulating membrane trafficking. It will be of
interest to determine whether important differences in func-
tion characterize the two GDI isoforms described here. The
cloning of the cDNA encoding the novel GDI-2 protein should
facilitate efforts to answer this question.
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